Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Research, science & health

Two researchers from the Paris Brain Institute rewarded by the 2022 ERC

Published on: 07/02/2023 Reading time: 1 min
Delphine OUDIETTE et Stéphanie BAULAC

The European Research Council (ERC) has just published the list of the winners of the grants it is about to distribute. This year, two researchers from at the Paris Brain Institute have been distinguished.

The ERC funds exploratory research projects, at the frontiers of knowledge, in all fields of science and technology. The only selection criterion is scientific excellence.

Two Paris Brain Institute researchers awarded

Delphine OUDIETTE, INSERM researcher in the team "MOV'IT: MOVEMENT, INVESTIGATIONS, THERAPEUTICS. NORMAL AND ANORMAL MOVEMENT: PHYSIOPATHOLOGY AND EXPERIMENTAL THERAPEUTICS" has obtained the support of the ERC* for her project "CREADOZE" on cognitive and neurophysiological processes characterizing the sleep onset period.

Sleep troubles -insomnia or excessive sleepiness- are a major public health issue. However, the way we fall asleep is poorly understood. Some gradual and dynamic changes are observed during the descent to sleep, on the behavioral (reduced responsiveness to stimuli), subjective (dream-like experiences called hypnagogia) and cognitive level (e.g. decline in executive functions, enhanced creativity).

Using high-density EEG, the project aims to understand how these markers fluctuate in relation to each other and to identify their brain signatures to better characterize the sleep onset period. The ultimate goal is to use neurofeedback to train individuals to control these markers to resist or embrace sleep according to their needs.

 

Stéphanie BAULAC, research director and head of the "GENETICS AND PHYSIOPATHOLOGY OF EPILEPSY" team, has received ERC support** for her project on the role of cell senescence in Focal Cortical Dysplasia (FCD), malformations of the developing brain leading to drug-resistant epilepsy in children.

In previous work, Stéphanie BAULAC's team has shown that FCD is due to brain somatic mutations.

The objective of the project is to evaluate the potential benefit of senolytics, molecules specifically targeting senescent cells, in experimental models of the pathology. Then, the goal is to propose a precision therapeutic treatment that could also benefit children not eligible for epilepsy surgery.

 

"Congratulations to these brilliant scientists, who will continue their innovative and hopeful research to better understand the brain and the diseases that affect it. These two successes bring to 19 the number of projects supported by the ERC since the creation of the institute, testifying to the scientific quality of the research conducted there", Prof. Alexis Brice, Director General of the Paris Brain Institute.

 

*Consolidator Grants: support for a researcher working on a scientific problem of excellence, exploratory, at the frontiers of knowledge.

** Proof of Concept Grants: to facilitate the exploration of the commercial and social innovation potential of research results previously supported by the ERC.

Our news on the subject

La huntingtine est une protéine indispensable au développement embryonnaire, à la formation et au maintien du tissu cérébral.
Huntington's Disease: The Energy Hypothesis Gets Traction
Huntington's disease, a rare hereditary neurological disorder, is associated with an energy deficit that precedes the onset of symptoms and is closely linked to their progression. At Paris Brain Institute, Fanny Mochel and her colleagues are testing...
02.11.2025 Research, science & health
À la recherche de marqueurs d’imagerie dans la démence frontotemporale
Searching for Imaging Markers in Frontotemporal Dementia
Could exploring the relationships between different brain networks help us understand frontotemporal dementia (FTD)? This neurodegenerative disease, which progresses at varying rates, is often diagnosed late—when clinical signs are already severe. At...
01.07.2025 Research, science & health
Stéphanie Debette
Professor Stéphanie Debette takes the helm of Paris Brain Institute
Appointed Executive Director of Paris Brain Institute for a five-year term, Professor Stéphanie Debette took up her new position on January 1, 2025. She succeeds Professor Alexis Brice, who has served as Executive Director since 2012.
01.07.2025 Institutional
Une chercheuse en train de travailler
Paris Brain Institute Announces Winners of the Second Edition of NeurAL, Its Acceleration Program for Innovative Projects
Paris, December 11, 2024. Identifying and supporting innovative neuroscience projects up to the creation of viable startups: this is the mission of iPEPS, Paris Brain Institute's startup studio. Through the NeurAL program, launched in 2023 and...
01.02.2025 Research applications
Monocyte – un globule blanc qui se différencie en macrophage. Crédit : Université d’Edinbourg.
Discovery of a Macrophage Anomaly in Multiple Sclerosis
Certain patients with multiple sclerosis (MS) can partially regenerate myelin—the protective sheath that surrounds nerve fibers—which is damaged during the evolution of the disease. In studying how immune cells influence this remyelination...
12.19.2024 Research, science & health
Interneurones. Crédit : UCLA Broad Stem Cell Research Center.
Stimulating specific neurons in the striatum stops compulsive behaviour
What if we could resist compulsions? These irrational behaviours, particularly common in obsessive-compulsive disorder (OCD), are hard to suppress. At Paris Brain Institute, Éric Burguière's team shows that we can anticipate them and block them...
09.10.2024 Research, science & health
See all our news